RESUMEN
To protect occupants in vehicle cabin environments from the health risks of high concentrations of particulate matter (PM), it is important to install vehicle cabin air filter (VCAF) to eliminate PM. In this study, we investigated the filtration performance of 22 VCAFs. Results showed that the minimum average filtration efficiency was 56.1 % for particles with a diameter of 0.1-0.3 µm, a pressure drop of 33.2-250 Pa at air velocity of 2.5 m/s, and the dust-holding capacity ranged from 5.8 to 19.4 g. In addition, as the filter area increased from 0.23 m2 to 0.50 m2, the filtration efficiency for particles with a diameter of 0.1-0.3 µm increased from 56.7 % to 77.5 %, the pressure drop decreased from 96.1 to 62.5 Pa, and the dust holding capacity increased 2.7 times. Furthermore, we compared the service life of VCAF from 31 major Chinese cities and found that the service life varied greatly from maximum of 1730 h for Haikou to minimum of 352 h for Shijiazhuang. Considering occupant health risks, Beijing requires that VCAFs have PM2.5 filtration efficiency at least 88.1 %, and Liaoning requires minimum of 97.5 %. Hence, choosing the appropriate VCAF based on the atmospheric environment of different cities deserves our attention.
RESUMEN
Objective: Aortic dissection, a rare but serious condition, requires timely diagnosis and treatment. Case report: A case report involving a 33-year-old female with Stanford type B aortic dissection at 32 + 3 weeks gestational age highlights the importance of being alert to the symptoms and signs of this condition, particularly in patients with hypertension or a history of connective tissue disorders. The case report suggests a delivery first strategy followed by TEVAR procedure as the preferred approach for managing aortic dissection in pregnancy. This approach can alleviate pressure on the aorta, reduce the risk of rupture, and provide time for stabilization and preparation for the TEVAR procedure. Conclusion: The case report emphasizes the criticality of recognizing and treating aortic dissection in pregnant patients promptly, given its potential life-threatening impact on both mother and fetus.
RESUMEN
Alginate-encapsulated hepatocyte transplantation is a promising strategy to treat liver failure. However, its clinical application was impeded by the lack of primary human hepatocytes and difficulty in controlling their quality. We previously reported proliferating human hepatocytes (ProliHHs). Here, quality-controlled ProliHHs were produced in mass and engineered as liver organoids to improve their maturity. Encapsulated ProliHHs liver organoids (eLO) were intraperitoneally transplanted to treat liver failure animals. Notably, eLO treatment increased the survival of mice with post-hepatectomy liver failure (PHLF) and ameliorated hyperammonemia and hypoglycemia by providing liver functions. Additionally, eLO treatment protected the gut from PHLF-augmented permeability and normalized the increased serum endotoxin and inflammatory response, which facilitated liver regeneration. The therapeutic effect of eLO was additionally proved in acetaminophen-induced liver failure. Furthermore, we performed assessments of toxicity and biodistribution, demonstrating that eLO had no adverse effects on animals and remained non-tumorigenic.